MAPK3 and familial pancreatic carcinoma: Additionally, the effects of ERK inhibitor (SCH772984) on T-cell leukemia/lymphoma cells via Cell Counting Kit-8 and flow cytometric analysis were consistent with the findings of a recent study on pancreatic cancer [28], which indicated that ERK1/2 pathway may play an important role in pterostilbene-induced apoptosis and cell cycle arrest.